Driving resource efficiency in the value-chain

Together with our customers, we are committed to balance the negative effect on the climate of air freight, with the social benefits of global access to life-saving pharmaceuticals.

Being a climate leader and trusted partner that decreases Greenhouse gas emissions and improves resource efficiency in the pharma cold chain.

Envirotainer aims to be a climate leader and a driving force to improve resource efficiency and by mitigating overall emissions in the pharma supply-chain together with our partners and customers. We are committed to balance the negative effect on the climate of airfreight, with the social benefits of global access to life-saving pharmaceuticals. In the pharma industry, the largest share of carbon emissions occurs in pharmaceutical production and raw material sourcing, whereas logistics and distribution of the products, using for example Envirotainer’s solutions, only makes up a fraction (approximately 5-10 percent) , making prevention of product loss during shipment the key priority for the industry.

As part of our strategy to decrease our emissions we work according to the principle of “reduce, promote and compensate”. This means that we first strive to mitigate our emissions where possible, including both our own operations and influencing our partners. Secondly, we should always promote the best solutions, looking at all aspects, to our customers. During 2021 we have increased our scope to also measure the emissions from our wholly owned stations in Atlanta, Amsterdam, Incheon and Singapore, as well as the operations centers in Frankfurt, Dallas and Singapore. Other partner stations and staff are not included.

For Envirotainer, this implies:

  • Improving resource efficiency by minimizing pharma product loss in the cold chain thanks to the high reliability of our solutions.
  • Further mitigating our own emissions, for example by using green energy and minimizing emissions from our production and service stations, and simultaneously reducing packaging waste by effective, efficient and circular use of the containers, with minimized unnecessary movements of the containers.
  • Contributing to mitigating the overall emissions in the pharma cold chain, by actively partnering with other participants in our eco-system to optimize shipment sizes, logistics flows and processes.

Strategic Objectives

  • Continue to mitigate emissions to maintain our own operations climate neutral.
  • Continuously decrease emissions per dose delivered in scope 3 use phase by advocating the consolidation to larger containers and decreasing unnecessary movements of empty containers.

KPIs

DRIVING RESOURCE EFFICIENCY IN THE VALUE-CHAIN 2021 2020 2019
% of trips without temperature deviations, % 99.9 99.9 99.4
Absolute CO2e for scope 1 and 2 and in scope 3 excluding use phase1) 6,291 tons2) 3,515 tons 4,234 tons
CO2e for scope 1 and 2 and in scope 3 excluding use phase per SEKm revenue 3.3 tons2) 2.2 tons 2.8 tons
CO2e for scope 1-2 and in scope 3 excluding use phase per SEKm revenue, after climate compensation 0 0 2.8 tons
CO2e / dose delivered including use phase in scope 3 0 1.9 kg 1.7 kg

1)Emissions in use-phase amounts for 99.5% of the total emissions
2) As of 2021 Envirotainer has enlarged the scope to also include emissions from the wholly owned stations in Atlanta, Amsterdam, Incheon and Singapore, as well as the operations centers in Frankfurt, Dallas and Singapore.

Read more about our emissions of Greenhouse Gases 2021, in the Sustainability Report 2021.

(Article updated 4/28/2022 4:07:11 PM)

Was this information helpful?